Skip to main content
SpringerLink
Log in

PARP inhibitors: risk of haematological toxicities

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials Cancers 15: No. 19, et al. Oct 2023. Available from: URL: https://doi.org/10.3390/cancers15194904

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PARP inhibitors: risk of haematological toxicities. Reactions Weekly 1979, 10 (2023). https://doi.org/10.1007/s40278-023-47737-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-47737-x

Search

Navigation